Hepatitis C Virus
Studies from University of Bristol, Department of Social Medicine further understanding of hepatitis C virus
Published in Vaccine Weekly, September 9th, 2009
Research findings, 'Assessing IDU prevalence and health consequences (HCV, overdose and drug-related mortality) in a primary care trust: implications for public health action,' are discussed in a new report. "We report on an exercise to estimate the prevalence of injecting drug use (IDU) and associated harms in a single primary care trust. Covariate capture-recapture methods to estimate (i) IDU prevalence; respondent driven sampling to measure (ii) prevalence of HCV and HIV and record linkage to measure (iii) mortality risk," scientists writing in the Journal of Public Health report.
"(i) The overall estimated number of IDU was 5540 (95% confidence interval, CI:...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2009-09-09)
More Articles from Vaccine Weekly
- Dana-Farber Cancer Institute
Study finds promise in combined transplant/vaccine therapy for high-risk leukemia - Infectious Diseases Society of America
Updated guidelines highlight primary care needs of those living with HIV - Yale University
Yale researcher questions federal guidelines for seasonal and swine flu vaccines - Bioterrorism
Research results from USA Scientific update understanding of bioterrorism - DNA Vaccines
Sichuan University details research in DNA vaccines - DNA Vaccines
Study findings from Sichuan University provide new insights into DNA vaccines - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
